Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

Not Recruiting

Trial ID: NCT02203565


This pilot clinical trial studies Dakin's solution in preventing radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a skin condition in which the affected skin becomes painful, red, itchy, and blistered. Dakin's solution may help reduce dermatitis caused by radiation therapy.

Official Title

Pilot Study to Investigate the Impact of Hypochlorite in the Prevention of Radiation Dermatitis

Stanford Investigator(s)


Inclusion Criteria:

   - Women with breast cancer who plan to undergo radiation therapy to the breast or chest

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Women with scleroderma or discoid lupus

   - Women with inflammatory breast cancer as evidenced by clinical assessment

   - Women with breast cancer involving the skin

   - Women who have undergone prior radiotherapy to the chest wall and/or breast


drug: Dakin's solution

radiation: radiation therapy

other: questionnaire administration

other: laboratory biomarker analysis

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Amanda Simmons

New Trial Alerts